Manuel Alejandro Gonzalez-Serna Martin

Plan Propio-Acceso
Área de conocimiento: Fisiología
Departamento: Fisiología
Grupo: Grupo Virología Clínica e ITS (CTS-1095)
Tipo Año Título Fuente
Artículo2023 Burden of significant liver damage in people living with HIV after microelimination of the hepatitis C virus. JOURNAL OF INFECTION
Artículo2023 Poor increase on HAV vaccination coverage among people living with HIV after an immunization-based intervention Enfermedades infecciosas y microbiología clínica
Artículo2022 Controlled attenuation parameter-insulin resistance (CIR) score to predict non-alcoholic steatohepatitis SCIENTIFIC REPORTS
Artículo2022 Discovering HIV related information by means of association rules and machine learning SCIENTIFIC REPORTS
Artículo2022 High efficacy of Glecaprevir/Pibrentasvir for HCV-Infected individuals with active drug use. JOURNAL OF INFECTION
Artículo2022 Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: a Spanish nationwide cohort HIV MEDICINE
Artículo2021 A genome-wide association study on liver stiffness changes during hepatitis c virus infection cure Diagnostics
Artículo2021 COVID-19 in hospitalized HIV-positive and HIV-negative patients: a matched study HIV MEDICINE
Artículo2021 How do women living with HIV experience menopause? Menopausal symptoms, anxiety and depression according to reproductive age in a multicenter cohort BMC WOMENS HEALTH
Artículo2021 Impact of recent drug use on the efficacy of Elbasvir/Grazoprevir for HCV-infected people on opioid agonist therapy. JOURNAL OF VIRAL HEPATITIS
Artículo2021 Incidence of recently acquired hepatitis C virus infection among HIV-infected patients in southern Spain HIV MEDICINE
Artículo2021 Liver stiffness change with HCV cure in HIV-infected patients on non-nucleoside analogues. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2021 Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy. PLOS ONE
Artículo2020 Effectiveness and safety of first-line antiretroviral regimens in clinical practice: a multicentre cohort study JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2020 Effectiveness of the combination elvitegravir/cobicistat/tenofovir/emtricitabine (EVG/COB/TFV/FTC) plus darunavir among treatment-experienced patients in clinical practice: A multicentre cohort study AIDS RESEARCH AND THERAPY
Artículo2020 High rate of major drug–drug interactions of lopinavir–ritonavir for COVID-19 treatment SCIENTIFIC REPORTS
Artículo2020 Physicians' opinions on generic antiretroviral drugs and single-tablet regimen de-simplification for the treatment of HIV infection: a multicentre survey in Spain JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2019 A genome-wide association study on low susceptibility to hepatitis C virus infection (GEHEP012 study) LIVER INTERNATIONAL
Artículo2017 Genotypic susceptibility score (GSS) and CD4+T cell recovery in HIV-1 patients with suppressed viral load JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Artículo2017 Increased CD127+and decreased CD57+T cell expression levels in HIV-infected patients on NRTI-sparing regimens JOURNAL OF TRANSLATIONAL MEDICINE
Letter2017 Rapid Decrease in Peripheral Blood Mononucleated Cell Telomere Length After HIV Seroconversion, but Not HCV Seroconversion JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
Artículo2017 Relationship between CCR5((WT/Delta 32)) heterozygosity and HIV-1 reservoir size in adolescents and young adults with perinatally acquired HIV-1 infection CLINICAL MICROBIOLOGY AND INFECTION
Artículo2016 A single untimed plasma drug concentration measurement during low-level HIV viremia predicts virologic failure CLINICAL MICROBIOLOGY AND INFECTION
Letter2016 Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naive patients DRUG DESIGN DEVELOPMENT AND THERAPY
Artículo2016 Validation of the HIV Tropism Test TROCAI Using the Virological Response to a Short-Term Maraviroc Monotherapy Exposure ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2014 HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure AIDS
Artículo2014 Performance of HIV-1 Drug Resistance Testing at Low-Level Viremia and Its Ability to Predict Future Virologic Outcomes and Viral Evolution in Treatment-Naive Individuals CLINICAL INFECTIOUS DISEASES
Artículo2014 Temporal trends in the discontinuation of first-line antiretroviral therapy JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Letter2013 "Test-and-Treat" Strategy for Control of HIV and AIDS Can Lead to a Decrease, Not an Increase, of Multidrug-Resistant Viruses CLINICAL INFECTIOUS DISEASES
Artículo2013 CD8 TCR beta chain repertoire expansions and deletions are related with immunologic markers in HIV-1-infected patients during treatment interruption JOURNAL OF CLINICAL VIROLOGY
Resumen congreso2013 HIV drug resistance occurring during low-level viraemia is associated with subsequent virological failure ANTIVIRAL THERAPY
Artículo2012 Correlation of the Virological Response to Short-Term Maraviroc Monotherapy with Standard and Deep-Sequencing-Based Genotypic Tropism Prediction Methods ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012 Different biological significance of sCD14 and LPS in HIV-infection: Importance of the immunovirology stage and association with HIV-disease progression markers JOURNAL OF INFECTION
Artículo2012 Effect of Maraviroc on HIV Disease Progression-Related Biomarkers ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012 HIV-1 Tropism Evolution after Short-Term Maraviroc Monotherapy in HIV-1-Infected Patients ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012 Patients on a combined antiretroviral therapy after maraviroc clinical test show no immunovirological impairment ANTIVIRAL RESEARCH
Artículo2011 Discordance rates between Trofile (R) test and short-term virological response to maraviroc ANTIVIRAL RESEARCH
Artículo2011 Virological Response after Short-Term CCR5 Antagonist Exposure in HIV-Infected Patients: Frequency of Subjects with Virological Response and Associated Factors ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2010 Long-Term Immunovirogical Effect and Tolerability of a Maraviroc-Containing Regimen in Routine Clinical Practice CURRENT HIV RESEARCH
Artículo2010 TROCAI (Tropism Coreceptor Assay Information): a New Phenotypic Tropism Test and Its Correlation with Trofile Enhanced Sensitivity and Genotypic Approaches JOURNAL OF CLINICAL MICROBIOLOGY
Artículo2009 Correlation between the Trofile (R) test and virological response to a short-term maraviroc exposure in HIV-infected patients JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Resumen congreso2007 Cytogenetic abnormalities in 350 patients diagnosed with B-cell chronic lymphocytic leukemiaand relationship with igvh mutational status HAEMATOLOGICA
Resumen congreso2001 Paclitaxel and rhG-CSF mobilizes a high amount of progenitor cells with a minimun number of apheresis and low toxicity in patients with lymphoma. BLOOD
Análisis de los ensayos de tropismo del VIH-1 TROCAI (2012)
Dirigida por: Ezequiel Ruiz-Mateos Carmona, Manuel Leal Noval

Este investigador no ha dirigido/tutorizado tesis
El investigador no tiene ningún proyecto asociado.
El investigador no tiene ningún resultado de investigación asociado